Eisai (company)

News and Video Search Results

News coverage

Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and Company, Merck Sharp & Dohme LLC, T

GlobeNewswire 02 May 2024

The dynamics of the inflammatory bowel disease market are anticipated to change in the coming years owing to the improvement in the..

BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire 29 Apr 2024
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono
PR Newswire Asia 25 Apr 2024
Breast Cancer Market To Reach USD 4.3 Billion By 2032, Says DataHorizzon Research
GlobeNewswire 23 Apr 2024
Sleep Medications Market to hit USD 38.7 Bn by 2032, says Global Market Insights Inc.
GlobeNewswire 23 Apr 2024

0 shares 1 views

You might like

Eisai (company) media coverage

Breast Cancer Therapeutics Market To Reach USD 53.2 Billion By 2032, Says DataHorizzon Research

GlobeNewswire 21 Apr 2024

The breast cancer therapeutics market size was valued at USD 28.4 Billion in 2023 and is expected to reach a market size of USD..

The Global Market for HPV Associated Disorders, 2018-2023 and 2024-2033, Featuring Profiles of Leading Players AstraZeneca, Roche, Biocon, GlaxoSmithKline, and Merck & Co
GlobeNewswire 19 Apr 2024
Blood Screening Market to Grow at CAGR of 11.6% through 2033; High Investment in Blood Transfusion Services to Bolster Growth
GlobeNewswire 18 Apr 2024
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
ACN Newswire 17 Apr 2024
Global Liver Cancer Drug Market to Reach USD 7.83 Billion by 2030: Innovative treatments like oncolytic viruses and RNA interference (RNAi) have gained market traction
GlobeNewswire 10 Apr 2024

Advertisement

More coverage

Excessive Daytime Sleepiness Market is Projected to Boost at a Moderate Growth Rate by 2032, Predicts DelveInsight | Key Companies in the Market - Avadel Pharmaceutical, Axsome Therapeutic, Theranexus, XWPharma, Takeda Pharmaceutical

GlobeNewswire 09 Apr 2024

The excessive daytime sleepiness market is expected to grow due to factors like an increase in the patient population due to a rise..

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics
ACN Newswire 03 Apr 2024
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
GlobeNewswire 29 Mar 2024
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
ACN Newswire 29 Mar 2024
[Latest] Global PARP Inhibitors Market Size/Share Worth USD 23.5 Billion by 2032 at a 12.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
GlobeNewswire 27 Mar 2024